Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Has results × Chocolate × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1 Cardiovascular Diseases 1

Interventions

Cyclophosphamide 776 Carboplatin 678 Paclitaxel 631 Bevacizumab 621 pembrolizumab 596 Cisplatin 588 Gemcitabine 529 Docetaxel 494 Radiotherapy 477 Rituximab 476 Dexamethasone 429 Nivolumab 401 Doxorubicin 381 Capecitabine 339 Fluorouracil 335 Etoposide 308 Oxaliplatin 288 Cytarabine 284 Pemetrexed 284 Lenalidomide 280 Prednisone 278 fludarabine phosphate 271 Erlotinib Hydrochloride 269 Leucovorin 261 fludarabine 258 Trastuzumab 251 Bortezomib 244 Filgrastim 243 Vincristine 242 Cetuximab 230

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02422745 2025-09-24

COSMOS

Brigham and Women's Hospital

Phase 4 Completed

21,442 enrolled 31 charts

Cardiovascular Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡